Psychotropic Drug Effects on Gene Transcriptomics Relevant to Alzheimer Disease (Q37852542)

24 August 2017

1 reference

title

Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease (English)

1 reference

24 August 2017

Psychotropic Drug Effects on Gene Transcriptomics Relevant to Alzheimer Disease (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

27 November 2024

0 references

0 references

1 reference

Edward C. Lauterbach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21399480

27 November 2024

language of work or name

English

0 references

publication date

1 January 2012

1 reference

24 August 2017

January 2012

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21399480

full work available at URL

27 November 2024

http://journals.lww.com/00002093-201201000-00001

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Alzheimer Disease and Associated Disorders

27 November 2024

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

1-7

1 reference

Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Genetic regulation of behavioral and neuronal responses to fluoxetine

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Genome-wide analysis of genetic loci associated with Alzheimer disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Clusterin: a forgotten player in Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Genomic convergence to identify candidate genes for Alzheimer disease on chromosome 10.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent cerebrolysin.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Human transferrin (Tf): a single mutation at codon 570 determines Tf C1 or Tf C2 variant

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

An association study between granulin gene polymorphisms and Alzheimer's disease in Finnish population.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Induction of interleukin-1 beta and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Reduction of thyroid hormone receptor c-ERB A alpha mRNA levels in the hippocampus of Alzheimer as compared to Huntington brain

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Overexpression of Tfam protects mitochondria against beta-amyloid-induced oxidative damage in SH-SY5Y cells

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Mitochondrial transcription factor A (TFAM) gene variation and risk of late-onset Alzheimer's disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphism

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Signal transduction through prion protein

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Prion protein protects human neurons against Bax-mediated apoptosis

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Early cognitive decline is associated with prion protein codon 129 polymorphism

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Prion protein codon 129 polymorphism and risk of Alzheimer disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Genetics of Alzheimer's disease: recent advances

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Identification of Alzheimer risk factors through whole-genome analysis.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Epigenetic dysregulation in cognitive disorders.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Introduction to behavioural and psychological symptoms of dementia (BPSD)

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Investigation of the role of the dopamine transporter in susceptibility to behavioural and psychological symptoms of patients with probable Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Role of serotonin transporter polymorphisms in the behavioural and psychological symptoms in probable Alzheimer disease patients

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data

27 November 2024

1 reference

https://api.crossref.org/works/10.1097/WAD.0B013E318214B7D0

27 November 2024

Identifiers

DOI

1 reference

24 August 2017

1 reference